Nomida.biz
Has Nomida.biz received an FDA warning letter about GLP-1 drugs?
Yes. FDA issued Nomida.biz a warning letter naming semaglutide and tirzepatide, dated Sep 12, 2024, with the FDA subject line “Unapproved New Drugs/Misbranded.”
FDA records in this index name Nomida.biz on Sep 12, 2024.
- Websites the letters name
- nomida.biz (see how each letter refers to them)
- Type named in FDA records
- Not stated
- FDA warning letters
- 1
- Drug recall reports
- 0
- Drugs named
- Semaglutide, Tirzepatide
- Latest record
- Sep 12, 2024
FDA warning letters
| Later letters FDA lists | Letter | |||
|---|---|---|---|---|
| Sep 12, 2024 | Unapproved New Drugs/Misbranded | Semaglutide, Tirzepatide | None listed by FDA as of Nov 15, 2026 | fda.gov |
A warning letter states FDA’s view when it was issued; it is not a court finding, and the company may have responded since. The later-letters column repeats what FDA’s warning letter index lists for each letter.
FDA’s summary excerpts
- Sep 12, 2024: … into interstate commerce unapproved and misbranded semaglutide and tirzepatide drug products. There are inherent … Forefront of Weight Loss Innovation,” you “specialize in Semaglutide and Tirzepatide, offering powerful solutions for … in the “Weight Loss” section of your website, you offer semaglutide marketed as “ SEMAGLUTIDE (10MG),” “ SEMAGLUTIDE … Full letter
Websites named in the letters
Each letter below is addressed to the firm FDA names in it, not to a website. The sentence quoted is the letter’s own reference to the site, copied from the letter on fda.gov.
- nomida.biz: FDA’s warning letter of Sep 12, 2024 is addressed to Nomida.biz. It refers to the site in these words: “… is to advise you that the United States (U.S.) Food and Drug Administration (FDA) recently reviewed your website at the Internet address www.nomida.biz and has observed that your website introduces into interstate commerce misbranded and unapproved new drugs in violation of sections 301(a), …” Full letter
Drug recalls
No openFDA drug recall reports in this index.
This page lists public regulatory records as published by the issuing agency. A record is not a finding by this site. A warning letter states the agency’s view at the time it was issued; companies may have responded or corrected the issue since. Follow each link for the original document and any close-out letter. Report an error or add a company response.
Sources
Records last pulled Nov 15, 2026. Every entry links to the original public record.